In this research, we first analyze the expression level of RILPL2 and summarize its prognostic roles, biological features, and correlation with tumor immune infiltration in EC patients, mainly according to the public data obtained from the Cancer Genome Atlas (TCGA) database. This evidence concerns the gene RILPL2 and neoplasm.